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[~  Psychosocial aspects of Turkish CF patients 
G. Cinel, D. Dogru, E. Yalcin, N. Cobanoglu, S. Pekcan, U. Ozcelik, B. Ulus, 
N. Kiper. Pediatric Pulmonology Unit, Hacettepe University Medical School, 
Ankara, Turkey 
As cystic fibrosis (CF) is an incurable disease, it has an impact on patients, their 
families. These children are at greater isk of having significant emotional or 
behavioural problems. Family demographics also have impact on their quality of 
life. 
Aims: To assess demographic measures and factors which affect psychosocial status 
of our patients. 
Methods: Parents of CF children completed a questionnaire on age at diagnosis, 
adhering to routine visits and treatments, occupational nd school problems, social 
activities, family structures and income, living conditions and problems with health 
insurance. 
Results: Data of 85 CF patients aged between 4 and 368 months (median 84 
months) were obtained. Median age at diagnosis is 4 months. 44.7% were not 
going to school, 41.2% were at elementary education, 3.5% attending to university. 
77.9% had 4 or more routine clinic visits annually. 62.4% had problems at school. 
14.1% had psychological ssistance. 35.3% had social activities like sports, music, 
painting and dancing. One patient smoked cigarettes and 57.6% of parents moked 
cigarettes at home. 30.6% didn't apply to their diet and 23.5% to physiotherapy. 
Their families consisted of median 4 persons; at least one person had a job and 
median income was E494. 18.8% of mothers and 31.8% of fathers were graduated 
from university, 1.2% of mothers had no formal education. 35.3% lived in rented 
houses and 42.4% used stoves for heating up their houses. 96.4% of patients' health 
expenditures were covered by government. 
Conclusion: Cigarette smoking, noncompliance with physiotherapy and diet, and 
family education are problems in Turkish CF patients. Information and support 
should be available to patients and their parents, to assist hem in coping with this 
chronic illness. 
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I~A review of pulmozyme use in children on Teesside 
F. Lindsay, F. Hampton, S. Kumar..James' Cook University Hospital, Middlesbrough, 
UK 
Background: Following the Pulmozyme Early Intervention Trial (Quan et al 2001) 
our use of Pulmozyme in children increased. 
Aim: To establish parents' perceptions of their child's health whilst using Pul- 
mozyme and to identify antibiotic use for one year before and after starting 
treatment. 
Method: Children under 18 who commenced treatment within the last 5 years 
and who had been diagnosed at least 1 year before starting Pulmozyme were 
included. Routine lung function measurements were documented. During clinic 
visits or routine telephone contact parents were questioned regarding their child's 
use of Pulmozyme. Questions related to timing of administration, their perception 
of concordance with treatment and their child's health status. A review of the case 
notes identified the antibiotic treatment of exacerbations. 
Results: Thirty six (57%) of patients attending clinic had been prescribed Pul- 
mozyme. Of these 24 fitted the above criteria. Fifteen (63%) maintained an 
FEV1 > 75% throughout the review. 83% of parents were questioned. Timing of 
Pulmozyme administration ranged from 30 minutes to 8 hours pre physiotherapy 
with 67% taking it immediately on return from school. Parents' and children found 
concordance easy and reported significant subjective benefits. Complete information 
on antibiotics was available for 18 patients, too few for statistical analysis. There 
were a median of 4 oral and 2.5 intravenous antibiotic ourses before treatment and 
2.5 and 2 after. Fifteen of 18 patients had a reduction in at least 1 type of antibiotic 
treatment. 
Conclusions: Parents perception of their child's health status during treatment with 
Pulmozyme was positive. This is reflected in maintenance of FEV1 and reduction 
in antibiotic use. Pulmozyme is easily adapted into family routine and concordance 
is reportedly high in comparison to other treatments. 
I •  Cultural restraints and barriers to physical activity for male 
CF adults 
D. Greenop, M.J. Walshaw, M.J. Ledson. Regional Adult CF Unit, The 
Cardiothoracic Centre, Liverpool, UK 
Introduction: Physical exercise is seldom a solitary activity but requires the 
participation or presence of other people, and as a social activity it is hypothesised 
that it is linked to the dominant cultural discourses of health and fitness. While 
the social structure of femininity militates against female participation i rigorous 
physical exercise, such activity is more acceptable tomales who have less resistance 
to this aspect of self-care. We aimed to explore the material, social and cultural 
barriers to physical activity for adult CF males. 
Methods: Using qualitative techniques, an independent research student (DG) com- 
pared the attitudes to exercise of 20 male CF adults (mean age 26 [range 18 43]) 
with 20 females (mean age 25 [range 18 39]) who had similar lung function (group 
data: 5 normal FEV1, 13 mild impairment, 14 moderate and 9 severe) selected by 
the CF team. 
Results: While males with mild disease were more physically active than similar 
females, this trend reversed with increasing disease and the ability to exercise 
rigorously ceased. Of the 17 participants with an FEV1 < 50% predicted (8 male), 
no males used public health promoting facilities, carried out housework, shopping, 
or went dancing, only 2 exercised through walking, and 5 did no exercise at all (for 
9 females: 5, 2, 3, 2, 6, and 3 respectively). 
Conclusions: Although this study supports the above hypothesis, it is apparent that 
adult CF males are influenced by cultural discourses of masculinity that may militate 
against participation in less rigorous physical activities such as walking. Thus, 
while the social construction of masculinity favours males when well, it disfavours 
them when unwell. The dominant masculine discourse creates a stigmatising effect 
(inducing insecurity/loss) for many adult males as their CF advances. 
1• Adherence to airway clearance therapies in patients with 
Cystic Fibrosis 
A.C. Modi 1 , M.K. Sontag 2, J.M. Koenig 2, F.J. Accurso 2, A.L. Quittner 3 & 
Investigators and Coordinators of the Airway Secretion Clearance Study. 
1Cincinnati Children~' Hospital Medical Center; 2University of Colorado at 
Denver and Health Sciences Center; 3 University of Miami, USA 
Airway clearance therapies (ACT) are important in clearing mucus from the lungs 
of patients with CE We examined adherence rates among patients randomized to 
three ACTs: postural drainage and percussion (PD&P), the Flutter TM, and high- 
frequency chest wall oscillation (HFCWO). This is one arm of a multi-center study 
of ACT. 
Adherence data was collected on 130 patients, (M age 14.2yrs; 54% male; 
M baseline FEV1% predicted 88.2%). Patients were stratified by age (7 12, 13 
17, and over 18 yrs) and randomized to PD&P (31%), Flutter (30%), and HFCWO 
(39%). Every 4 months patients completed a Daily Phone Diary, a computerized 
24-hr recall of daily activities, including ACT adherence. 
We found differences in adherence after randomization for all patients using PD&P 
(64%) vs. both Flutter (47%, p < 0.01) and HFCWO (54%, p < 0.10). Differences 
were also found between Flutter (49%) and HWFCO (60%) at 1-yr follow-up 
(p < 0.10). We found differences in adherence for adolescents after randomization, 
between Flutter (33%) and PD&P (69%, p 0.03), but not HFCWO (50%). Ad- 
herence for Flutter (32%) was significantly lower than PD&P (81%, p 0.03) and 
HFCWO (66%, p 0.01) 1-yr later. No statistical differences were found between 
ACTs for children or adults. 
Data suggest hat ACT type does not appear to affect adherence in children and 
adults. However, adolescents appeared to be more adherent to HFCWO and PD&P 
compared to Flutter, and adherence increased over time for these ACTs. Better 
adherence to these treatments may be related to the amount of supervision by 
parents of adolescents. 
Study supported by Hill-Rom, Inc., and the CF Foundation. 
